ã€ãŒãã³ ãã¡ãŒãã·ã¥ãŒãã£ã«ã«ãºç€Ÿã¯ãåžå°çŸæ£ã®å»è¬åã®éçºãšåååã«æ³šåããå°é補è¬äŒç€Ÿã§ããå瀟ã¯ã麻é
æã®è¡ç®¡æ¡åŒµãäž»å ãšãªãèšåºçã«é倧ãªäœè¡å§ã®æ²»çãç®çãšãããã§ãã¬ããªã³æ³šå°å€ãããªã«ãã§ã³ãã17 æ³æªæºã®å°å
ã®å¯è
ç®è³ªæ©èœäžå
šã®è£å
çæ³ãã¢ã«ãã³ã㣠ã¹ããªã³ã¯ã«ããã¢ã¬ã«ã®ãŒæ§çµèçã®æ²»çãç®çãšããé²è
å€äžäœ¿çšã®ç¹çŒè¬ãã¢ã©ãŠã§ã€ ããªã¶ãŒããã£ã ããªãŒããæäŸããŠããŸãããŸããã©ã¢ããªã®ã³çµå£æžæ¿æ¶² ET-105ãã·ã¹ãã€ã³æ³šå°å€ DS-300ãç¡æ°Žã¢ã«ã³ãŒã«æ³šå°å€ DS-100ããŸããµããçµå£æžæ¿æ¶² ET-104ãããã©ããŒãçµå£æžæ¿æ¶² ET-101ããšãã§ããªã³ã®å³äœ¿çšå¯èœæ³šå°å€ ET-203 ãéçºããŠããŸãã Eton Pharmaceuticals, Inc. 㯠2017 幎ã«èšç«ãããã€ãªãã€å·ãã£ã¢ããŒã¯ã«æ¬ç€Ÿã眮ããŠããŸãã